APPARATUS FOR WOUND THERAPY THAT FORMS A CHAMBER OVER THE WOUND
20180169395 ยท 2018-06-21
Inventors
Cpc classification
A61F9/0026
HUMAN NECESSITIES
International classification
Abstract
Method and apparatus for protecting and treating wounds are provided. A housing is adapted to be adhesively secured over the wound of an injured or infected person. The housing has an opening for access to the wound, and is further provided with inlet and outlet ports for the application of therapeutic materials. There is particularly provided a program for a closed looped system for such wound care. Additionally, the invention provides for a protective and treating cover for the eye, which can be either opaque or translucent. Additionally, a mechanism for accurately depositing eye drops without risking injury to the eye is also provided.
Claims
1. A wound therapy apparatus, comprising: a housing sealingly securable to skin around a wound by an adhesive layer that sealingly encloses a perimeter of the housing to form a chamber about the wound that is fluid tight; a therapeutic modality deliverable within the chamber to the wound, the therapeutic modality comprising gas at a pressure that differs from ambient pressure, the gas directly contacting the wound; and wherein the housing comprises: a base enclosing a perimeter and being open at a first end and open at a second end; a cushion having an open interior, the cushion secured around the first end of the base to cushion the base upon securement of the housing around said wound, an adhesive layer that sealingly secures the cushion to the skin with at least portions of the adhesive layer interposed between the cushion and the skin around a cushion perimeter of the cushion when the cushion is secured to the skin; and an openable lid attached sealingly around the second end of the base.
2. The apparatus of claim 1, further comprising: a programmable device that cooperates with the chamber to control the delivery of the therapeutic modality within the chamber to the wound.
3. The apparatus of claim 2, further comprising a sensor in communication with the programmable device and in communication with the chamber.
4. The apparatus of claim 1, wherein the therapeutic modality comprises cyclical oxygen.
5. The apparatus of claim 1, wherein the therapeutic modality comprises cyclical suction.
6. The apparatus of claim 1, wherein the therapeutic modality further comprises the gas at positive pressure greater than ambient pressure in combination with the gas at negative pressure less than ambient pressure within the chamber.
7. The apparatus of claim 1, wherein the gas consists essentially of oxygen.
8. The apparatus of claim 1, wherein the therapeutic modality includes delivering cyclically pressures of nitric oxide within the chamber to the wound.
9. The apparatus of claim 1, wherein the therapeutic modality further comprises a therapy selected from the group consisting of proteolytic enzymes, lavages, nitric oxide, healing factors, immune modulators, moxibustion, controlled humidity, and controlled temperature.
10. The apparatus of claim 1, wherein the lid is formed of transparent material for viewing of the chamber through the lid.
11. A wound therapy apparatus, comprising: a housing securable to skin around a wound by an adhesive layer that sealingly encloses a perimeter of the housing to form a chamber that is fluid-tight over the wound, the housing comprising an openable lid; a source of gas to fluidly communicates with the chamber to deliver cyclical pressure changes of the gas within the chamber, the cyclical pressure changes comprise positive pressure greater than ambient pressure in combination with negative pressure less than ambient pressure.
12. The wound therapy apparatus of claim 11, the gas comprises air.
13. The wound therapy apparatus of claim 11, the gas consists essentially of oxygen.
14. The wound therapy apparatus of claim 11, the gas comprises humidity.
15. The wound therapy apparatus of claim 11, further comprising: a sensor in communication with the chamber to detect pressure within the chamber; a programmable device that communicates with the sensor and that cooperates with fluid communication of the gas with the chamber to control the cyclical pressure changes in the chamber in response to pressure within the chamber detected by the sensor.
16. The wound therapy apparatus of claim 11, further comprising: a cushion secured around the housing to cushion the housing when the housing is in sealing securement to skin around the wound, the cushion being selected as an inflatable cushion or a closed cell foam cushion.
17. The wound therapy apparatus of claim 11, the housing being compression-resistant.
18. The wound therapy apparatus of claim 11, further comprising: a therapy for delivery within the chamber to the wound, the therapy selected from the group consisting of proteolytic enzymes, lavage, nitric oxide, healing factor, immune modulator, moxibustion, controlled humidity, and controlled temperature.
19. A wound therapy apparatus, comprising: a housing that forms a chamber over a wound that is fluid-tight when secured to the skin around the wound by an adhesive layer that sealingly encloses a perimeter of the housing; a therapeutic modality delivered within the chamber to the wound; a programmable device that cooperates with the chamber to control the delivery of the therapeutic modality; and wherein the housing comprises: a base enclosing a perimeter and being open at a first end and open at a second end; a cushion having an open interior, the cushion secured circumferentially around the first end of the base to cushion the base upon securement of the housing around said wound by securement of the cushion to the skin using the adhesive layer, portions of the adhesive layer being interposed between the cushion and the skin, the cushion being an inflatable air cushion or a closed cell foam cushion; and an openable lid disposed about the second end of the base.
20. The method of claim 1, wherein the therapeutic modality comprises cyclical oxygen.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0033] For a complete understanding of the objects, techniques and structure of the invention, reference should be made to the following detailed description and accompanying drawings wherein:
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
DETAILED DESCRIPTION OF PREFERRED EMBODIMENT FOR CARRYING OUT THE INVENTION
[0049]
[0050] Over the left eye is shown one embodiment of this invention in the form of an eye dressing chamber 20. A lid or cover 22 that can be clear or of variable tint and opacity covers a form fitting conforming base ring which is adhesive mounted to enclose the entire periorbital area. The lens can open and close via locking means 26 and is attachable to the base ring via a hinge mechanism 24. Further construction detail is provided in
[0051]
[0052]
[0053]
[0054]
[0055] In this illustrated embodiment, the cover 22 of the eye wound chamber is attached to the base ring via a living hinge 24 similar to the type found commonly on toothpaste caps and shampoo bottles. The hinge provides a tendency to remain in either the open or closed positions, the first tendency is useful during direct examination by the physician or for medication dispensing. The cover is secured to the base ring at the opposing end by any of a number of latching means.
[0056]
[0057] When using the eye dropper dome as described in
[0058]
[0059] Attachment structures such as retainer posts 78 can optionally be part of the cover 22 to allow items of benefit to be held within the chamber above the wound 72. This is further discussed under
[0060] The wound chamber can additionally have an optional inlet port 74 and outlet port 76, adapted to receive infusion lines that may be uni- or bidirectional medical tubing. Again, for clarity's sake, the exact structures of these ports are not shown but any of a number of suitable medical ports and coupling mechanisms may be used and substituted. These include simple compression-fit ports, multi-way stopcocks, luer-lock, and self sealing membrane ports as commonly found in central venous catheters and other advanced vascular catheters.
[0061] The inlet port 74 may be placed anywhere on the lid or base chamber of the wound chamber and should generally be in direct proximity to the wound. However, the drainage port 76 should ideally be in the most dependent portion of the chamber to facilitate drainage. Through the inlet and outlet ports, a circulation of chilled or heated air or oxygen may be infused depending on the nature and therapeutic needs of the wound. The air or oxygen may further be humidified. Other gases such as nitric oxide, which has vasodilator and cellular signaling properties, can also be used. Instead of needing a hyperbaric chamber, high oxygen concentration to the wound can easily be attained locally without the attendant cost and toxicity complications. All that is needed is to keep the wound chamber filled with pure oxygen, a very simple and economical task accomplished by infusing the gas from a small reservoir. Additionally, cycles of gentle or pulsatile lavage with saline or proteolytic enzymes can be passed through efficiently using a programmable pump system as shown in
[0062] If the chamber 70 is to be used for therapies requiring fluid-tightness so that the fluids stay within the chamber, the foam should be of the closed-cell type. The term fluid-tight or related terms as used in this specification means sufficiently leak-resistant to allow insufflation or vacuum suction to create an intra-chamber pressure that is above or below ambient pressure, or to substantially retain fluids within. Various cyclical patterns of fluid application can be programmed to optimize the wound chamber milieu selected from the following: [0063] 1) Application of a local anesthetic [0064] 2) Application of a saline lavage with the effluent collected for centrifuge, cytoanalysis, microbial culture, etc. [0065] 3) If wound is contaminated with cellular and/or microbial debris, infusion of proteolytic enzymes such as papain, trypsin, collagenase, Bacillus subtilis protease, vibriolysin, krill protease, chymotrypsin, clastase, dipase, proteinase K, and Clostridium multifunctional protease [0066] 4) Application of an antimicrobial [0067] 5) Application of wound healing factors and immune modulators [0068] 6) Application of oxygen at ambient or above-ambient pressure [0069] 7) Application of nitric oxide [0070] 8) Application of low suction.
[0071] After a dirty wound is cleaned, there is no longer a need to apply lavage and proteolytic digestion cycles. At this point, the therapy focuses on delivery of oxygen and other beneficial fluids and the application of a cycle of intermittent positive and negative pressures, lasting one to several minutes per cycle. This simulates the normal vascular flow of the circulatory system at the tissue level.
[0072] When positive pressure is applied in the form of pure oxygen, oxygen is driven into the tissue and capillaries along a favorable gradient and the interstitial pressure rises pushing cellular edema into lymphatic channels to decrease the local swelling. Next, the programmable pump system reverses the pressure gradient to slightly negative, creating suction that brings fresh blood flow, along with all the inherent beneficial factors to the wound. This cycle is repeated, with cycles of other beneficial therapies such as nitric oxide, interposed. For cost saving and portable module size considerations, it may be desirable to filter effluent gases such as oxygen and nitric oxide and recycle their use. In such an arrangement, after several cycles, the gases could be completely purged and new aliquots of gases introduced.
[0073]
[0074] The cover element 22 can be interchangeably attached to the base via a detachable hinge or any of a number of disconnectable engagement means that are apparent to those skilled in the arts
[0075] Turning attention now back to
[0076] The applicator pad 146 is used as a paint brush to apply a layer of cyanoacrylate over all of the surface area that would be covered by the footprint of the wound chamber except for the wound itself. This layer of cyanoacrylate now provides multiple benefits including: [0077] 1) enabling the chamber base to adhere stronger and better; [0078] 2) minimize incidence of adhesive sensitivity by providing a durable barrier; [0079] 3) protect skin from maceration secondary to prolonged contact with liquids; [0080] 4) discouraging the unwanted migration of maggots and leeches via a chemical mat; and [0081] 5) dull the disturbing proprioceptive sensations patients experience when the above creatures wander outside of the wound.
[0082] An alternative method to preventing skin maceration includes the application of a polymer film that attaches to the skin via adhesive on the underside. The disadvantage of this method is that wound shapes are typically irregular, so the polymer has to be cut or trimmed to fit around the wound edge. In contrast, the novel method described using cyanoacrylate requires only a few seconds of fast painting with a sponge applicator.
[0083]
[0084] Wound boot 100 is shown with two openable hatches, a front hatch 110 to access the toes, and a posterior hatch 112 to access the heel. These hatches are reversibly attachable to the main boot via single action latches 114 or dual action latches 116 that have mechanisms similar to those commonly found on ski-boots and tool boxes. Many other attaching and latching means are available and will not be elaborated. One or more anchoring means 120 such as the loop shown at the toe end, allows the boot to be suspended via ropes 122 for elevation either to improve drainage or for medical examination. Infusion inlets 74 and outlets 76 are positioned to allow optimal fluid flow and drainage. Depending on the desired application, the boot may need to be of a much thicker construction than the wound chamber of
[0085] It should be apparent that similar designs can be made to accommodate and contour to other pressure areas such as the elbow or buttocks, or to accommodate frequent surgical sites such as the breast. It would be apparent to those skilled in the art that such chambers should generally be of lowest feasible profile, be pressure diffusing and provide secure anchoring means. Where the wound chamber can provide a source of contact pressure to adjacent tissue such as the contralateral leg, such pressure can be reduced by placing a soft sponge sock or other padding over the general area of contact.
[0086]
[0087] Audio capabilities include alarms and speech synthesis. Alarms include reservoir low/empty alarm, pressure and temperature malfunction alarm, time elapsed alarm, etc. which may be wirelessly transmitted to caretaker as an alert. Temperature sensor includes means for heating or cooling the chamber or fluids delivered therein.
[0088] This block diagram is to illustrate an example only. The actual implementation may vary and would be readily apparent to those skilled in the art.